Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion
Status:
Terminated
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
This trial was performed to evaluate the safety and the efficacy of G-CSF based stem cell
therapy in patients with AMI. MAGIC Cell-1 trial enrolled patients with acute and old
myocardial infarction, and had two groups of cell infusion, and G-CSF alone. MAGIC Cell-2
trial enrolled patients with acute myocardial infarction presented within 12 hours after
onset of chest pain who underwent successful primary PCI. We randomized patients into the
G-CSF group and the control group.